ID: ALA3245768

Max Phase: Preclinical

Molecular Formula: C19H30Cl2N2O2

Molecular Weight: 317.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[N+](C)(C)CCCNCC(O)COc1cccc2ccccc12.Cl.[Cl-]

Standard InChI:  InChI=1S/C19H29N2O2.2ClH/c1-21(2,3)13-7-12-20-14-17(22)15-23-19-11-6-9-16-8-4-5-10-18(16)19;;/h4-6,8-11,17,20,22H,7,12-15H2,1-3H3;2*1H/q+1;;/p-1

Standard InChI Key:  APMPWDNHIUSGNN-UHFFFAOYSA-M

Associated Targets(non-human)

Heart 171 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 317.45Molecular Weight (Monoisotopic): 317.2224AlogP: 2.27#Rotatable Bonds: 9
Polar Surface Area: 41.49Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.12CX LogP: -2.27CX LogD: -3.99
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.55Np Likeness Score: -0.13

References

1. Rauls DO, Baker JK..  (1979)  Relationship of nonspecific antiarrhythmic and negative inotropic activity with physicochemical parameters of propranolol analogues.,  22  (1): [PMID:423187] [10.1021/jm00187a018]

Source